scholarly journals Effectiveness of New Antibiotic Combination Therapy for Active Ulcerative Colitis : A Case Report

2010 ◽  
Vol 76 (2) ◽  
pp. 118-119
Author(s):  
Hiroto Ishii ◽  
Shintaro Tsukinaga ◽  
Shunichi Odahara ◽  
Kan Uchiyama ◽  
Katsushi Amano ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Case Report ◽  
Combination Therapy ◽  
Active Ulcerative Colitis ◽  
Antibiotic Combination

S1749 Serial Changes of Cytokines in Active Ulcerative Colitis: Effects of Antibiotic Combination Therapy

2009 ◽  
Vol 136 (5) ◽  
pp. A-262 ◽  
Author(s):  
Kunihiko Sato ◽  
Toshimi Chiba ◽  
Toshifumi Ohkusa ◽  
Kazuyuki Suzuki
Keyword(s):  
Ulcerative Colitis ◽  
Combination Therapy ◽  
Active Ulcerative Colitis ◽  
Antibiotic Combination

scholarly journals Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature

2021 ◽  
Vol 8 (1) ◽  
pp. e000587
Author(s):  
Giacomo Caio ◽  
Lisa Lungaro ◽  
Fabio Caputo ◽  
Maria Muccinelli ◽  
Maria Caterina Marcello ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Case Report ◽  
Inflammatory Bowel Diseases ◽  
Drug Toxicity ◽  
Active Ulcerative Colitis ◽  
Extraintestinal Manifestations ◽  
Review Of The Literature ◽  
Extraintestinal Manifestation ◽  
Bowel Diseases ◽  
Inflammatory Bowel

Inflammatory bowel diseases such as ulcerative colitis (UC) may be complicated by several extraintestinal manifestations. These involve joints, skin, eyes and less commonly lungs and heart. Myocarditis may result from the toxic effect of drugs (ie, mesalazine) commonly used for the treatment of UC or due to infections (eg, Coxsackieviruses, enteroviruses, adenovirus). Here, we report a case of a 26-year old man affected by UC and complicated by two episodes of myocarditis. Both episodes occurred during two severe exacerbations of UC. However, in both cases the aetiology of myocarditis remains uncertain being ascribable to extraintestinal manifestation, drug toxicity or both.

Effectiveness of Antibiotic Combination Therapy Targeting Intestinal Bacteria for Ulcerative Colitis

2015 ◽  
Vol 110 ◽  
pp. S813
Author(s):  
Hiroko Kobayashi ◽  
Shintaro Tsukinaga ◽  
Tomoya Kanai ◽  
Shinichiro Takami ◽  
Keisuke Saito ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Combination Therapy ◽  
Intestinal Bacteria ◽  
Antibiotic Combination

Antibiotic combination therapy in patients with chronic ulcerative colitis

2003 ◽  
Vol 124 (4) ◽  
pp. A68 ◽  
Author(s):  
Toshifumi Ohkusa ◽  
Hiroto Miwa ◽  
Osamu Kobayashi ◽  
Tsuyoshi Terai ◽  
Tetsuya Nomura ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Combination Therapy ◽  
Chronic Ulcerative Colitis ◽  
Antibiotic Combination

scholarly journals Treatment of Ulcerative Colitis and Seronegative Inflammatory Spondyloarthritis With Vedolizumab and Tofacitinib

2020 ◽  
Vol 26 (11) ◽  
pp. e146-e146
Author(s):  
Joy A Lee ◽  
Pooja R Magavi ◽  
Gauree G Konijeti
Keyword(s):  
Ulcerative Colitis ◽  
Case Report ◽  
Combination Therapy

The case report describes the benefits of combination therapy with vedolizumab and tofacitinib in a patient with ulcerative colitis and seronegative inflammatory spondyloarthritis.

Off-Line Leukapheresis Using Leukofiltration for Active Ulcerative Colitis: A Case Report

2001 ◽  
Vol 5 (6) ◽  
pp. 480-483
Author(s):  
Yoshihiro Endo ◽  
Hideyuki Tsuzuki ◽  
Mitsuhiro Fujino ◽  
Takahisa Tabata ◽  
Hiroshi Oka ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Case Report ◽  
Active Ulcerative Colitis
Sign in / Sign up

Export Citation Format

Share Document